Diligence memo · auto-generated · as of July 2, 2026

Medical Records Now, Inc.

Medical Records Now, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Medical Records Now, Inc. operates in Healthtech, based in KALISPELL.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Medical Records Now, Inc. has raised $2.0M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $1.0M on 2018-07-01.

Most recent recorded round closed around 2019-07-01.

Valuation (modeled)modeled

Provath models Medical Records Now, Inc. at approximately $34M (range $627K–$391M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.33× the median modeled value of Pre-Seed Healthtech companies in 2019–2021 (139 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.

Financing rhythm & timingmixed

Historic cadence: a new round about every 12 months.

Last raise 7.0 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 38% of Healthtech peers (2138 compared).

Modeled value ranks above 55% of those peers.

Closest niche peers: Levin Eye Care LLC, Emf Medical Devices Inc., Miracle Leaf Health Centers, Corp., PRINE Health Holdings, LLC, nView medical Inc..

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.